Outcomes of Antiviral Retreatment for Immunocompromised Hosts With Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Positivity: A Multicenter Australian Retrospective Case Series
Details
Publication Year 2024-08,Volume 11,Issue #8,Page ofae449
Journal Title
Open Forum Infectious Diseases
Publication Type
Research article
Abstract
Outcomes are presented for a multisite retrospective case series, describing a contemporary cohort of 22 immunocompromised patients with persistent coronavirus disease 2019 (COVID-19) polymerase chain reaction positivity who were retreated with antiviral therapy. For those with data available 14 and 30 days after commencement of antiviral therapy, 41% (9 of 22) and 68% (15 of 22), respectively, cleared COVID-19.
Publisher
Oxford University Press
Department(s)
Infectious Diseases
Open Access at Publisher's Site
https://doi.org/10.1093/ofid/ofae449
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-09-10 01:56:37
Last Modified: 2024-09-10 01:58:24

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙